文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

CLDN3 和 CLDN4 在卵巢肿瘤发生过程中的去抑制与抑制性组蛋白修饰的丢失有关。

Derepression of CLDN3 and CLDN4 during ovarian tumorigenesis is associated with loss of repressive histone modifications.

机构信息

Laboratory of Molecular Pathology, Department of Pharmacy, College of Pharmacy, Seoul National University, 599 Gwanak-ro, Gwanak-gu, Seoul 151-742, Korea.

出版信息

Carcinogenesis. 2010 Jun;31(6):974-83. doi: 10.1093/carcin/bgp336. Epub 2010 Jan 6.


DOI:10.1093/carcin/bgp336
PMID:20053926
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2878357/
Abstract

Unlike epigenetic silencing of tumor suppressor genes, the role of epigenetic derepression of cancer-promoting genes or oncogenes in carcinogenesis remains less well understood. The tight junction proteins claudin-3 and claudin-4 are frequently overexpressed in ovarian cancer and their overexpression was previously reported to promote the migration and invasion of ovarian epithelial cells. Here, we show that the expression of claudin-3 and claudin-4 is repressed in ovarian epithelial cells in association with promoter 'bivalent' histone modifications, containing both the activating trimethylated histone H3 lysine 4 (H3K4me3) mark and the repressive mark of trimethylated histone H3 lysine 27 (H3K27me3). During ovarian tumorigenesis, derepression of CLDN3 and CLDN4 expression correlates with loss of H3K27me3 in addition to trimethylated histone H4 lysine 20 (H4K20me3), another repressive histone modification. Although CLDN4 repression was accompanied by both DNA hypermethylation and repressive histone modifications, DNA methylation was not required for CLDN3 repression in immortalized ovarian epithelial cells. Moreover, activation of both CLDN3 and CLDN4 in ovarian cancer cells was associated with simultaneous changes in multiple histone modifications, whereas H3K27me3 loss alone was insufficient for their derepression. CLDN4 repression was robustly reversed by combined treatment targeting both DNA demethylation and histone acetylation. Our study strongly suggests that in addition to the well-known chromatin-associated silencing of tumor suppressor genes, epigenetic derepression by the conversely related loss of repressive chromatin modifications also contributes to ovarian tumorigenesis via activation of cancer-promoting genes or candidate oncogenes.

摘要

与肿瘤抑制基因的表观遗传沉默不同,促进癌症的基因或癌基因的表观遗传去抑制在癌症发生中的作用仍知之甚少。紧密连接蛋白 Claudin-3 和 Claudin-4 在卵巢癌中经常过表达,其过表达先前被报道可促进卵巢上皮细胞的迁移和侵袭。在这里,我们表明 Claudin-3 和 Claudin-4 的表达在与启动子“双价”组蛋白修饰相关的卵巢上皮细胞中受到抑制,包含激活的三甲基化组蛋白 H3 赖氨酸 4(H3K4me3)标记和抑制性标记三甲基化组蛋白 H3 赖氨酸 27(H3K27me3)。在卵巢肿瘤发生过程中,CLDN3 和 CLDN4 表达的去抑制与除三甲基化组蛋白 H4 赖氨酸 20(H4K20me3)外,另一种抑制性组蛋白修饰的 H3K27me3 的丢失相关。尽管 CLDN4 的抑制伴随着 DNA 超甲基化和抑制性组蛋白修饰,但在永生化卵巢上皮细胞中,CLDN3 的抑制不需要 DNA 甲基化。此外,卵巢癌细胞中 CLDN3 和 CLDN4 的激活与多个组蛋白修饰的同时变化相关,而单独的 H3K27me3 丢失不足以使其去抑制。CLDN4 的抑制通过靶向 DNA 去甲基化和组蛋白乙酰化的联合治疗得到了强有力的逆转。我们的研究强烈表明,除了众所周知的肿瘤抑制基因的染色质相关沉默之外,通过相反相关的抑制性染色质修饰的表观遗传去抑制也通过激活促进癌症的基因或候选癌基因有助于卵巢肿瘤发生。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/254f/2878357/295302c17e13/carcinbgp336f05_ht.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/254f/2878357/3b4086cb86a4/carcinbgp336f01_ht.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/254f/2878357/df7d804ae78c/carcinbgp336f02_lw.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/254f/2878357/543b12a57228/carcinbgp336f03_ht.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/254f/2878357/17ef2b394ff6/carcinbgp336f04_ht.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/254f/2878357/295302c17e13/carcinbgp336f05_ht.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/254f/2878357/3b4086cb86a4/carcinbgp336f01_ht.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/254f/2878357/df7d804ae78c/carcinbgp336f02_lw.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/254f/2878357/543b12a57228/carcinbgp336f03_ht.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/254f/2878357/17ef2b394ff6/carcinbgp336f04_ht.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/254f/2878357/295302c17e13/carcinbgp336f05_ht.jpg

相似文献

[1]
Derepression of CLDN3 and CLDN4 during ovarian tumorigenesis is associated with loss of repressive histone modifications.

Carcinogenesis. 2010-1-6

[2]
Claudin-4 overexpression is associated with epigenetic derepression in gastric carcinoma.

Lab Invest. 2011-8-15

[3]
Regulation of the CLDN3 gene in ovarian cancer cells.

Cancer Biol Ther. 2007-11

[4]
Crucial roles of Sp1 and epigenetic modifications in the regulation of the CLDN4 promoter in ovarian cancer cells.

J Biol Chem. 2006-7-28

[5]
Tight junction proteins claudin-3 and claudin-4 are frequently overexpressed in ovarian cancer but not in ovarian cystadenomas.

Clin Cancer Res. 2003-7

[6]
Tight junction proteins claudin-3 and claudin-4 control tumor growth and metastases.

Neoplasia. 2012-10

[7]
Expression profile of tight junction protein claudin 3 and claudin 4 in ovarian serous adenocarcinoma with prognostic correlation.

Histol Histopathol. 2007-11

[8]
Potential roles of claudin-3 and claudin-4 in ovarian cancer management.

J Egypt Natl Canc Inst. 2022-6-6

[9]
Regulation of the Epithelial-Mesenchymal Transition by Claudin-3 and Claudin-4.

PLoS One. 2013-6-21

[10]
Recombinant CPE fused to tumor necrosis factor targets human ovarian cancer cells expressing the claudin-3 and claudin-4 receptors.

Mol Cancer Ther. 2009-7

引用本文的文献

[1]
Establishment of an ovarian cancer exhausted CD8+T cells-related genes model by integrated analysis of scRNA-seq and bulk RNA-seq.

Eur J Med Res. 2024-7-5

[2]
The histone methyltransferase SUV420H2 regulates brown and beige adipocyte thermogenesis.

JCI Insight. 2024-5-7

[3]
Claudin-4: A New Molecular Target for Epithelial Cancer Therapy.

Int J Mol Sci. 2023-3-13

[4]
H4-methylation regulators mediated epitranscriptome patterns and tumor microenvironment infiltration characterization in hepatocellular carcinoma.

Clin Epigenetics. 2023-3-17

[5]
The role and mechanism of claudins in cancer.

Front Oncol. 2022-12-22

[6]
Analyses of the expression and prognosis of ILDR1 in human gastric cancer.

Heliyon. 2022-8-27

[7]
Hypomethylation of Gene Promoter Is Associated with Malignant Phenotype in Urinary Bladder Cancer.

Int J Mol Sci. 2022-6-10

[8]
Context-Dependent Roles of Claudins in Tumorigenesis.

Front Oncol. 2021-7-20

[9]
Epigenomic regulation of human T-cell leukemia virus by chromatin-insulator CTCF.

PLoS Pathog. 2021-5

[10]
Tight junctions and their regulation by non-coding RNAs.

Int J Biol Sci. 2021

本文引用的文献

[1]
Identification of novel reference genes using multiplatform expression data and their validation for quantitative gene expression analysis.

PLoS One. 2009-7-7

[2]
Minireview: epigenetic changes in ovarian cancer.

Endocrinology. 2009-9

[3]
Recombinant CPE fused to tumor necrosis factor targets human ovarian cancer cells expressing the claudin-3 and claudin-4 receptors.

Mol Cancer Ther. 2009-7

[4]
Epigenetic landscaping during hESC differentiation to neural cells.

Stem Cells. 2009-6

[5]
Claudin-3 gene silencing with siRNA suppresses ovarian tumor growth and metastasis.

Proc Natl Acad Sci U S A. 2009-3-3

[6]
Chromatin signatures in multipotent human hematopoietic stem cells indicate the fate of bivalent genes during differentiation.

Cell Stem Cell. 2009-1-9

[7]
Roles of the EZH2 histone methyltransferase in cancer epigenetics.

Mutat Res. 2008-12-1

[8]
DACT3 is an epigenetic regulator of Wnt/beta-catenin signaling in colorectal cancer and is a therapeutic target of histone modifications.

Cancer Cell. 2008-6

[9]
Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation.

Nat Genet. 2008-6

[10]
Mechanisms involved in the regulation of histone lysine demethylases.

Curr Opin Cell Biol. 2008-6

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索